Articles tagged with Cancer Cells
A new study suggests that cell fusion can initiate cancerous processes and tumor formation through 'genomic catastrophe', leading to chromosomal instability and DNA damage. Fused cells from rat intestinal epithelial cells formed tumors in immunodeficient mice, providing evidence for a molecular mechanism driving neoplastic transformation.
Scientists at Scripps Research Institute found that a natural compound called leinamycin (LNM) E1 can be activated by reactive oxygen species, leading to DNA damage and cell death in cancer cells. The study reveals promising therapeutic potential for LNM E1 against prostate and other cancers.
Researchers at Arizona State University identify five foundations of multicellularity that cancer cells bypass to fulfill their selfish needs, leading to disastrous outcomes for the organism. The study provides clues about how to diagnose and treat cancer, a disease with rapid evolution capabilities.
Researchers discovered that double-strand breaks occur at replication fork stalling sites due to collision. The study found that non-homologous end-joining is the primary repair method used in this context, despite its potential for errors.
Researchers at The Wistar Institute have discovered how a specific variant of the condensin protein complex plays a crucial role in regulating DNA structure and promoting cellular senescence. This finding provides valuable insights into the anti-cancer activity of cells and could lead to the development of new therapies
Researchers at OIST Graduate University mapped the points along the genome where a scaffolding protein called condensin binds. Condensin is essential for reassembling copied genomic fragments into chromosomes and maintaining genetic integrity.
A team of researchers at the IRCM has made a breakthrough discovery about how DNA is organized in our cells. They found that two specific proteins play an essential role in maintaining the proper structure of chromatin.
A recent study found that the thunder god vine extract reduces food intake by up to 80% and causes a 45% decrease in body weight in obese mice. The compound Celastrol enhances leptin action, a hormone signaling fullness to the brain, improving ER function and sensitivity.
Researchers at Winship Cancer Institute of Emory University have discovered a novel strategy to exploit apoptosis in lung cancer treatment by inhibiting the Bcl-2 protein. A new class of compounds has been identified that bind to the BH4 domain of Bcl-2, promoting cancer cell death.
Researchers have designed a nanoparticle-based therapy that effectively treats mice with multiple myeloma, a cancer of immune cells in the bone marrow. The nanoparticles carry a Myc inhibitor, which blocks a protein active in many types of cancer, and increase survival by 23 days compared to control groups.
Researchers from the University of Cambridge captured the process of cytotoxic T cells destroying cancer cells using state-of-the-art imaging techniques. The study reveals the remarkable precision and efficiency with which these cells patrol our bodies, identifying and eliminating virally infected and cancerous cells.
Researchers found that MET inhibitors can have a double-edged effect on tumors, promoting cell-cycle arrest or death in cancer cells while blunting pro-inflammatory reactions in neutrophils. This discovery could lead to optimizing cancer treatment by stratifying patients based on MET expression and dependency.
Scientists at CSHL have developed a method to comprehensively identify binding pockets inside cancer cells that can be targeted by drugs. Using CRISPR, they surveyed about 200 potential targets and identified six known targets and 19 new ones in leukemia cells.
A study published in the Journal of Cell Biology suggests that new understanding of cell division can reveal potential targets for cancer therapy. Researchers have identified key steps in cell division and highlighted novel targets that could be inhibited to block cancer cell division.
Mark Grimes, a UM professor, used new data analysis techniques to study childhood cancer called neuroblastoma. He discovered functional compartmentalization of signaling proteins in cancer cells, which could lead to triggering cell death and improving therapeutic progress.
Research suggests that statin use may delay resistance to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer. Statins block the uptake of dehydroepiandrosterone sulfate, a precursor of testosterone, thereby prolonging time to disease progression.
Researchers at UNC School of Medicine have created a method to find where DNA repair happens throughout the entire human genome. This breakthrough could lead to better and more effective cancer drugs or improvements in existing ones.
Scientists at University of California, San Diego School of Medicine demonstrate ability to reprogram large parts of a cell's signaling network by manipulating key hub in communication networks. This approach shows potential to slow or reverse disease progression, including cancer driven by abnormal cell signaling.
Researchers observe complex biochemical interactions between nerves and cancer cells, challenging conventional wisdom on perineural invasion. This dance-like movement allows cancer cells to invade nerves, leading to poor patient survival and severe complications.
Researchers found that paternally contributed centriole proteins can persist up to ten cell generations, raising the possibility that centrioles may be a non-genetic information carrier. This discovery has profound implications for biology and disease treatment, particularly for understanding centriole-related diseases.
A Purdue University study reveals that cancer drug decitabine combats cell damage by taking the place of nucleotide cytosine, restoring 'meaning' to garbled gene messages. An uptick in 5-hydroxymethylcytosine levels could indicate cancer treatment success.
Researchers discovered that Myc's primary function is to repress well-being genes, making cancer cells vulnerable to cell death. This finding suggests a new approach for cancer therapies, targeting the downregulation of well-being genes to enhance the killer activity of Myc in tumor cells.
University at Buffalo researchers have discovered a way to easily and effectively fasten proteins to nanoparticles, showing promise for developing an HIV vaccine and targeting cancer cells. The new biotechnology uses modified proteins and nanoparticles made of natural pigments and metal, and has been tested with impressive results.
Research reveals FGFR1 amplification in 22.7% of small cell lung cancer tumors, implying applicability to non-small cell lung cancer treatments
Researchers have discovered a protein called LEM that promotes the proliferation of cytotoxic T cells, which kill cancer cells and cells infected with viruses. The discovery could lead to new gene therapies designed to boost infection-fighting cells and provide a robust treatment for patients.
Alessandro Vindigni's research reveals four-way junctions as a critical mechanism for resolving DNA lesions, enabling cells to resume replication and maintain genetic stability. New enzymes, including DNA2, play a key role in this process.
Researchers discovered a previously invisible biological process that may be implicated in the rapid growth of some cancers. The new study reveals that a well-known cancer protein called mTOR can hand off its work to another protein, CDK1, when cells are dividing.
Researchers have developed a method to increase radiation's effectiveness in killing cancer cells by using gold nanoparticles tethered to acid-seeking compounds. The approach, published in PNAS, shows promising results and may improve radiation treatment for cancer patients.
A new study has found a significant link between muscle-building supplements and an increased risk of developing testicular cancer. Men who used these supplements were more than 65% likely to develop the disease compared to those who did not use them.
A recent study published in the JNCI: Journal of the National Cancer Institute found a surprising association between shorter telomeres and decreased cancer mortality. The researchers analyzed data from two prospective cohort studies involving over 64,000 individuals and discovered that those with longer telomeres had higher genetic sc...
Researchers at the University of York have found a potential new treatment for organ-confined prostate cancer using low-temperature plasmas. The study, published in the British Journal of Cancer, suggests LTPs may be a viable alternative to current radiotherapy and photodynamic therapy treatments.
Acute myeloid leukemia (AML) cells exhibit high genetic diversity, driven by convergent evolution and mutation rates, leading to increased treatment resistance. Researchers are exploring a new paradigm that leverages cancer's evolveability to develop more effective treatments.
A new molecule designed to specifically target a cancer-causing transcription factor has shown potential to extend survival in some leukemia patients. The small molecule, AI-10-49, inhibits the progression of acute myeloid leukemia (AML) by sequestering an oncogenic mutant, leaving normal transcription factor activity intact.
Researchers at the University of Missouri-Columbia found that 6-Thioguanine can change how certain cancer cells function, weakening them so they can be killed by other drugs. This discovery could lead to future cancer treatments using combination therapy.
A new MRI technique can detect cancerous cells by identifying telltale sugar molecules shed by the outer membranes of cancerous cells. This method could potentially replace or enhance current imaging tests like mammograms and CT scans, allowing for earlier diagnosis and more effective treatment.
This special issue delves into the latest research on molecular gastronomy, perception of food, growing crops, obesity, and diet's impact on the circadian clock. Researchers discuss the science behind cooking techniques, flavor creation, and how chefs are pioneering new fermentation reactions.
Dr. Sara A. Courtneidge is being recognized by the American Association for Cancer Research (AACR) for her groundbreaking research on Src-family kinases and their role in cancer development. Her work has also focused on promoting women in science, leadership, and mentorship.
Low is being recognized for his pioneering development of low molecular weight ligands to deliver attached therapeutic and imaging agents selectively into pathologic cells such as cancer cells. This targeted therapeutic approach improves potency and reduces toxicity.
Researchers at the University of Virginia have developed a promising drug that targets a specific altered cellular protein driving acute myeloid leukemia. The compound kills cancerous cells while sparing healthy ones, offering a new paradigm for treating leukemia.
Cells sort out hairpin-loop structures meant to encode small RNAs, known as microRNAs, using a specific chemical tag. The discovery has wide-ranging implications for development, health and disease, including cancer.
Researchers discover that combining Sodium Formate with metal-based cancer treatment JS07 can greatly increase its effectiveness against ovarian cancer cells. The potent form of JS07 disrupts cancer cell's energy generation mechanism, leading to cell shutdown and potential reduction in side effects.
Researchers discovered that minor clones present at low levels in leukemia cells often drive relapse, contradicting the assumption that mutated cells with more mutations are more likely to survive therapy. The study's findings have implications for monitoring patients in remission and detecting signs of relapse.
Researchers in Berlin have successfully generated human T cell receptors that specifically recognize and destroy cancer cells. The breakthrough, published in Nature Biotechnology, could lead to new cancer therapies by training the immune system to attack tumor cells.
Scientists have created buckybombs, nanoscale explosives that could target and eliminate cancer cells at the cellular level without affecting surrounding tissue. The new explosives were built by attaching nitrous oxide molecules to a Bucky-Ball and then heating it, triggering a controlled explosion.
Researchers at the University of Leeds have discovered a rare African bush that may help treat kidney cancer. The Phyllanthus engleri plant contains a chemical called Englerin A, which activates specific proteins in renal cancer cells, leading to their death.
Researchers develop a novel approach to drug design using diabodies to tune cytokine receptor signaling. The method shows promise in targeting cancer cells and has the potential to reduce side effects by selectively blocking pathologic signals.
Researchers at the University of Sydney have discovered a key RNA mechanism that helps plants adapt to their environment, which could lead to improved crop yields and gene therapies for diseases like cancer. The findings also suggest similar mechanisms exist in humans, providing new avenues for medical research.
Researchers at Walter and Eliza Hall Institute developed a new genome-editing technology to target and kill blood cancer cells. The CRISPR/Cas9 system was used to delete an essential gene for cancer cell survival, showing promise for treating human diseases arising from genetic errors.
Two proteins critical for maintaining healthy day-night cycles also protect against mutations that could lead to cancer. The study found that these proteins have an unexpected role in DNA repair, stabilizing a protein called Cry1 and preventing errors in DNA transcription.
Scientists studying human cervical epithelial cells found that distinct fractal patterns emerge only at the point of progression towards cancer. These findings could inspire targeting specific weak points in pathways leading to cancer development. Fractal patterns may hold importance in understanding cancer metastasis, where cancer cel...
Theoretical chemists generate maximally random, jammed states using a computer algorithm, revealing new insights into the nature of randomness. These findings have implications for materials science and photonics, where randomly dispersed patterns can create unique properties.
Intermediate filaments of vimentin 'insulate' mitochondria in cancer cells from destruction, preserving energy reserves. This discovery may lead to the development of new drugs that effectively treat cancer.
Chemists at Bielefeld University develop copper-based anti-tumor agent that targets DNA phosphates, disrupting cellular processes and killing cancer cells. The new agent shows higher efficacy than cisplatin in killing cancer cells at lower concentrations.
Researchers identified a genetic variation associated with increased risk and severity of peripheral neuropathy in young leukemia patients treated with vincristine. The high-risk CEP72 variant may allow for reduced vincristine doses without compromising cancer treatment efficacy.
A study by Brigham and Women's Hospital researchers uses epigenomic maps to predict a cancer's cell type of origin, providing new insights into early cancer events. This discovery could help guide treatment decisions for patients with unknown primary sites, which pose significant challenges.
A new study suggests that understanding species extinction can help drive cancer cells to annihilation. The authors identify two critical factors governing species resistance to extinction: evolveability and robustness to perturbations. These characteristics may have important correlates among some types of cancer cells.
Scientists have created a new model organism for studying aging in the naturally short-lived African turquoise killifish. The researchers developed a genome-editing toolkit, allowing them to rapidly manipulate genes and study aging-related diseases.
A new approach, called an evolutionary trap, steers cells into one evolutionary path while shutting off others, then knocks out the cell population for good. The strategy may be applied to various clinical scenarios where drug resistance is a problem.
Researchers at McGill University developed a powerful new intraoperative probe for detecting cancer cells in real time during surgery. The Raman spectroscopy probe has a greater than 92% accuracy in identifying invasive brain cancers, and its use may improve patient outcomes by reducing cancer recurrence and extending survival times.
Scientists have created a conjugate molecule that targets and suppresses prostate cancer growth in mice, using a near-infrared dye and MAO-A inhibitor. The compound NMI shows promise as a therapeutic and diagnostic tool for prostate and other cancers.